OpenAI’s delayed IPO timeline to 2027, driven by CEO Sam Altman’s September 2026 emphasis on resolving AI safety and alignment issues ahead of any listing, underpins current Polymarket odds favoring straightforward ticker symbols. Traders have assigned the highest implied probabilities to $OAI at 47% and $OPAI at 35%, reflecting the company’s $1.4 trillion valuation target in recent private funding rounds and the precedent for concise, brand-aligned symbols in high-profile tech debuts. Lower-priced outcomes such as $OA and $CGPT capture residual bets on abbreviated or product-linked variants, while the market’s aggregated capital at risk highlights uncertainty over final regulatory and exchange approvals closer to the expected 2027 window.